Literature DB >> 19892528

Activity of tigecycline against recent European clinical isolates of Clostridium difficile.

Stephen P Hawser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892528     DOI: 10.1016/j.ijantimicag.2009.09.009

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  7 in total

Review 1.  Future novel therapeutic agents for Clostridium difficile infection.

Authors:  Hoonmo L Koo; Kevin W Garey; Herbert L Dupont
Journal:  Expert Opin Investig Drugs       Date:  2010-07       Impact factor: 6.206

2.  Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.

Authors:  Casey M Theriot; Cassie A Schumacher; Christine M Bassis; Anna M Seekatz; Vincent B Young
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

3.  Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection.

Authors:  Christine M Bassis; Casey M Theriot; Vincent B Young
Journal:  Antimicrob Agents Chemother       Date:  2014-03-03       Impact factor: 5.191

4.  Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin.

Authors:  Dominador Lao; Tom Chiang; Eric Gomez
Journal:  Case Rep Med       Date:  2012-07-09

5.  Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection.

Authors:  Nicholas S Britt; Molly E Steed; Emily M Potter; Lisa A Clough
Journal:  Infect Dis Ther       Date:  2014-12-03

Review 6.  Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection.

Authors:  Yuan-Pin Hung; Jen-Chieh Lee; Hsiao-Ju Lin; Hsiao-Chieh Liu; Yi-Hui Wu; Pei-Jane Tsai; Wen-Chien Ko
Journal:  Antibiotics (Basel)       Date:  2015-06-19

Review 7.  Novel Antimicrobials for the Treatment of Clostridium difficile Infection.

Authors:  Nicola Petrosillo; Guido Granata; Maria Adriana Cataldo
Journal:  Front Med (Lausanne)       Date:  2018-04-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.